Home › Funds › FORMULA GROWTH LTD › TOI
FORMULA GROWTH LTD position in TOI
STARLING ONCOLOGY INC
FORMULA GROWTH LTD reported holding 368,400 shares of TOI (STARLING ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.90% of its reported portfolio and ranking #28 among its reported holdings. FORMULA GROWTH LTD has disclosed TOI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How FORMULA GROWTH LTD's TOI position evolved
FORMULA GROWTH LTD first disclosed a stake in TOI in Q2 2026 at 300,000 shares (US$1.6M). The position peaked in Q3 2026 at 368,400 shares, worth US$2.3M. Across 2 filings, FORMULA GROWTH LTD increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 368,400 shares valued at US$2.3M — an increase of 68,400 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 300.00K | $1.63M | New |
| Q3 2026 | 368.40K | $2.33M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TOI and 13F data
TOI (STARLING ONCOLOGY INC) is a company whose sector is not yet classified in our data. 68 other funds we track also report a position in TOI — the largest reported positions include JOSH ARNOLD INVESTMENT CONSULTANT, LLC (US$13.4M), WEXFORD CAPITAL LP (US$10.8M), BRC Group Holdings, Inc. (US$4.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TOI
- JOSH ARNOLD INVESTMENT CONSULTANT, LLC 2.46M sh · $13.38M · Q2 2026
- WEXFORD CAPITAL LP 1.71M sh · $10.82M · Q3 2026
- BRC Group Holdings, Inc. 722.38K sh · $4.57M · Q3 2026
- FourWorld Capital Management LLC 499.20K sh · $2.71M · Q2 2026
- Manatuck Hill Partners, LLC 450.00K sh · $2.44M · Q2 2026
- Dauntless Investment Group, LLC 163.57K sh · $888.18K · Q2 2026
- Panoramic Capital, LLC 100.00K sh · $543.00K · Q2 2026
- Spark Investment Management LLC 72.80K sh · $460.10K · Q3 2026
- T3 Companies, LLC 64.50K sh · $407.64K · Q3 2026
More on FORMULA GROWTH LTD
FAQ
How long has FORMULA GROWTH LTD held TOI?
FORMULA GROWTH LTD has disclosed TOI holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is FORMULA GROWTH LTD's current position in TOI?
As of Q3 2026, FORMULA GROWTH LTD holds 368.40K shares of TOI (STARLING ONCOLOGY INC), valued at $2.33M, representing 0.90% of its reported portfolio and ranking #28.
Has FORMULA GROWTH LTD been buying or selling TOI?
In the latest 13F filing (Q3 2026), FORMULA GROWTH LTD increased its position in TOI. The position peaked in Q3 2026 at 368.40K shares.
Which other funds hold TOI?
Other major institutional holders of TOI include JOSH ARNOLD INVESTMENT CONSULTANT, LLC, WEXFORD CAPITAL LP, BRC Group Holdings, Inc., among 68 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.